Award
Delivery Order #SPE2DR26F6DLU
AmerisourceBergen Awarded Delivery Order for Clobetasol Propionate Foam
Buyer
Defense Logistics Agency
Award Amount
$48.84
Ceiling
$48.84
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26F6DLU
NAICS
424210
This award represents a delivery order contract issued under a long-term indefinite delivery vehicle (IDV) awarded previously to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract covers the procurement of a specific pharmaceutical product, Clobetasol Propionate 0.05% Foam (50GM), which is a topical corticosteroid medication used to treat various skin conditions. The significance of this award lies in its support to federal healthcare supply chains by ensuring the timely availability of essential medications. The scope of work includes the delivery of this specialized pharmaceutical product for immediate use within a short timeframe. This award follows a competitive procurement process under the umbrella of the existing IDV contract, reaffirming AmerisourceBergen's role as a trusted pharmaceutical distributor. The delivery order is scheduled for a brief performance period starting and ending in early 2026, reflecting the urgent and precise nature of this provision within the broader contract framework.
Description
4570810924!CLOBETASOL PROP 0.05% FOAM 50GM